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Abstract 
Purpose: Magnesium (Mg) is a key factor in blood pressure regulation. However, 
only in recent years, magnesium dietary intake has been studied in relation to hyper-
tension, with equivocal conclusions. Further no comparisons have previously been 
made between the UK general population and primary hypertensives, the UK RNI 
and the USARDA. Methods: Twenty-five hypertensives (HT) (mean age 63.4 y) and 
twenty-one normotensives (mean age 46.7 y) were recruited from the same geo-
graphical area. Food diaries were completed and analysed to determine average daily 
Mg intake. Mg intake was compared between the observed group (OB), normoten-
sives (NT) and general population (GP) and both the UK RNI and the USA RDA. 
Results: Study participants had a significantly lower dietary Mg intake than the UK 
RNI (p < 0.05) and the US RDA (p < 0.05). Intake for HT males was significantly 
lower (p < 0.0001) than the external control (general population) and, for HT fe-
males, intake was significantly lower than the NT (p = 0.006). The findings also sug-
gest that with ageing there is a reduction in daily dietary Mg intake. Finally, when 
UK external controls were compared to the USA RDA for both males and females 
they were found to be around 35% and 30% respectively below the recommended 
values. Conclusions: Daily Mg intake in hypertensives is lower than the general 
population, the UK RNI and the USA RDA. Daily magnesium intake reduces with 
age. These findings suggest that low Mg dietary intake increases the risk of hyperten-
sion. 
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1. Introduction 
Increasing evidence suggests a key role for magnesium in the regulation of blood pres-
sure [1] [2] and a deficiency of it has been demonstrated to contribute to a number of 
disease states such as type 2 diabetes, metabolic syndrome, elevated C reactive protein 
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and hypertension [3]. Observational studies have shown an inverse association between 
dietary magnesium intake and blood pressure (BP) [2] [4] [5]; however, a number of 
meta analyses examining magnesium supplementation have produced conflicting re-
sults [1] [6] [7] [8] [9] [10]. Experimental studies have suggested that a deficiency in 
magnesium may have detrimental effects on blood pressure and the cardiovascular sys-
tem, and previous studies have examined the effect of magnesium supplementation on 
hypertension [11] [12] [13] yet there are limited studies that look at long term dietary 
intake and association with HT. A study by Chidambaram (2014) [14] looked at the In-
dian population and divided participants into normotensive and hypertensive groups 
and found that a reduction in Mg consumption was associated with increased blood 
pressure. However, this study looked only at urinary biomarkers and not food intake. 
Choi and Bae (2015) [15] investigated Mg intake in Koreans. The participants were 
grouped into quartiles of magnesium intake and BP assessed. Women were found to 
have a negative relationship between magnesium intake and HBP. However, this study 
did not include those on HT tablets or those with previously diagnosed HT. This cur-
rent study aims to look at the association between habitual dietary Mg intake and those 
with existing HT. 
Magnesium is the fourth most abundant cation in the body, involved in more than 
300 enzymatic systems [16]. Total body stores vary between 21 - 28 g in the average 70 
kg adult with most of the magnesium being stored in the bone mass, the remainder is 
found in soft tissue with only 0.3% in extra-cellular stores [16], this makes magnesium 
measurement difficult and is the reason why dietary magnesium intake is often the best 
measure of hypomagnesia.  
Elevated blood of Mg can cause vasodilation and reduce vasoconstriction of the vas-
culature in common with other minerals such as Ca2+, a key contributor to vascular 
smooth muscle constriction [17] [18]. Magnesium exhibits a pharmacological profile 
comparable to a synthetic calcium channel antagonist; therefore, it has been suggested 
to be nature’s “physiological calcium blocker” [19]. 
Few intervention studies have examined the effect of habitual dietary magnesium in-
take on blood pressure. Furthermore, there have been no assessments of habitual dieta-
ry magnesium intake in those clinically diagnosed as hypertensive. Therefore, the aim 
of this investigation is to determine if there is an association between habitual dietary 
magnesium intake and hypertension. 
A study by Ohira et al., (2009) [20] attempted to determine whether there was a cor-
relation between dietary magnesium intake and serum magnesium concentrations in 
relation to CVD risk. They found that individuals with both dietary and serum mag-
nesium greater than the median had an approximately 35% lower risk of ischemic 
stroke.  
The Honolulu heart study undertaken by Joffres, Reed and Yano, (1987) [21] dem-
onstrated an inverse relationship between dietary magnesium supplementation and 
both systolic (SBP) and diastolic blood pressure (DBP). When dietary Mg without addi-
tional supplementation was studied, results were similar although the link with DBP 
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was reduced (r = 0.6). In contrast, a cross-sectional study using data from the National 
Health and Nutrition Examination Survey (NHANES) [22] reported no significant 
correlation between magnesium and blood pressure but a limitation of the study was 
the fact it did not allow for directional or causal influences. The absence of firm con-
sensus despite a demonstrated mechanistic link between the blood pressure reducing 
action of Mg suggests that dietary Mg intake is worthy of further investigation. 
The current RNI in the UK is 300mg and 270mg daily for males and females respec-
tively from 18 - 75+ years [23]. For the USA the Recommended Dietary Allowance 
(RDA) is 400 mg and 310 mg for males and females respectively from ages 19 - 30 years 
and 420 - 320 mg daily for those aged >31 years old [24]. The National Diet and Nutri-
tion Survey [23] states that the average consumption of the RNI in the UK is at 90% for 
males and 82% for females, representing a population consuming less than recom-
mended. This study therefore sets out to determine whether those with primary hyper-
tension habitually eat a diet that is both lower than the RNI and lower than the UK na-
tional average for age and sex. Further consideration will be given to how this compares 
to the USA RDA with a substantially higher recommended intake. As the UK national 
average intake is already lower than the RNI these will be compared to the higher RDA 
used in the USA to observe the greater difference between intake in the UK and rec-
ommendation in the USA. 
According to Long Term Health Conditions [25] 1 in 4 adults is affected by high 
blood pressure in the UK. Figures show that by reducing the blood pressure of the na-
tion as a whole, £850 million of NHS and social care costs could be avoided over 10 
years. Further, if 15% more people currently being treated for high blood pressure 
could control it better a further £120 million could be saved [25]. To date there have 
been no studies investigating the dietary intake of those with hypertension with regard 
to magnesium intake from habitual dietary intake.  
2. Materials and Methods 
Twenty-five participants (female n = 11, male n = 14, mean age 63.4 ± 10.2 y) were re-
cruited from the East and North Herts NHS Trust. Ethical approval was granted by 
North and East Herts Local Research Ethics Committee. Individuals already diagnosed 
with primary hypertension (and not hypertension caused by either other medical con-
ditions or drug intervention) were identified by a Consultant Cardiologist and were re-
cruited as subjects. Written informed consent was obtained during their appointments 
with the cardiologist. Thirty-three subjects were recruited with 8 excluded for non- 
completion.  
A further 21 normotensive participants (female n = 11, male n = 10, mean age 46.7 ± 
10.6y) were recruited from the same geographical area to act as internal controls (NT). 
Participants were excluded if they suffered from hypertension (BP ≥ 140/90) or were 
being medicated for the condition, a pre-study blood pressure recording was underta-
ken to confirm this. All participants completed a 4-day food diary in week 1 including 3 
mid-week days and 1 weekend day, this was repeated in week 4. The food diary was 
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adapted from The Medical Research Council Collaborative Centre for Human Nutri-
tion Research, National Diet and Nutrition Survey [26]. Although classified as an esti-
mated food diary, food could be weighed and food labels submitted, in addition to 
photos being provided to establish portion size. All food diaries were recorded between 
January and March. An external control of the general UK population (GP) aged 19y 
and over was established from data provided by the National Diet and Nutrition Survey 
(NDNS) [23]. The two control groups were measured against each other to ensure ho-
mogeneity between groups to validate the food diary analysis and no statistically signif-
icant difference was found between the external observed and internal control groups 
for both the males (p = 0.6) and females (p = 0.12), except for the fact that the internal 
control group’s mean intake of Mg was more than the RNI (See Table 1). 
All diaries were analysed using Dietplan 6 (Forestfield software Ltd. West Sussex 
UK). Data were analysed for skewness and kurtosis and one way ANOVA used for in-
terpretation of differences using SPSS (Version 22, IBM New York, USA). 
Average daily magnesium intake established from the 8 day food diaries were com-
pared between the HT, NT and GP groups and these were compared to both the UK 
RNI and the USA RDA to establish differences amongst the hypertensives and the re- 
commendations. 
The magnitude of the differences between observed and control groups were ex-
pressed as the effect size using Cohen’s d, calculated as the absolute difference between 
means divided by the pooled SD [27]. Qualitative descriptors of the effect size were as 
follows: negligible (d < 0.19), small (d = 0.20 - 0.49), moderate (d = 0.50 - 0.79), or large 
(d > 0.8). 
3. Results 
Mean Mg intake of the hypertensive males (HT) was compared to that of the normo-
tensive male controls (NT) and the general UK population (GP) (90% of the RNI) as 
well as the RNI (Figure 1). A significant difference in dietary magnesium intake was 
seen between the HT group and the GP group (p < 0.0001) and the RNI (p < 0.0001). 
The observed group did not show a significant difference in intake compared to the in-
ternal control group, although a trend could be seen (p = 0.14) with a moderate effect 
size of 0.6 shown between the groups. 
Mean Mg intake of the hypertensive females was compared against that of normo-
tensive females, the general population and the RNI (Figure 2). The HT group had a  
 
Table 1. Mean Mg intakes (mean ± SD) for all participants (HT + NT) stratified by age group (n 
= number of participants). 
Age range All Mg (mg/d) 
19 - 50y 244 ± 65 (n = 17) 
51 - 64y 259 ± 79 (n = 16) 
65 + y 200 ± 45 (n = 14) 
All 236 ± 69 (n = 47) 
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significantly lower mean dietary Mg intake than the RNI (p = 0.006) and the NT group 
(p = 0.006). However, there was no significant difference between the HT group and 
the GP (p = 0.264). An effect size of 0.4 was found between the HT group and the GP 
control corroborating with the lack of significance between these two groups.  
When total data (hypertensive and normotensive together) for both males and fe-
males were analysed, a one way ANOVA showed that there was a significant difference 
between the age groups (p = 0.042) (Table 1). 
In females there is a reduction of over 100 mg/day between all participants (both HT 
and NT) aged 51 - 64 y and those aged 65 y and above giving a 37% reduction in intake.  
 
 
Figure 1. Mean +/− SD male daily magnesium intake comparing the hypertensive, normo-
tensive, general UK population and the RNI (+denotes significant difference between ob-
served and RNI, *denotes significant difference between HT and the GP with p ≤ 0.05). 
 
 
Figure 2. Mean (± SD) female daily magnesium intake comparing the observed, internal con-
trol, external control groups with the RNI, (+denotes significant difference between observed 
and RNI, *denotes significant difference between HT and NT (p ≤ 0.05). 
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For males the greatest difference was 31 mg between the 18 - 50 yr and 65+ yrs popula-
tion groups (Figure 3). 
Male UK data for both the HT and NT was compared against the USA RDA (Figure 
4). A significant difference in mean daily magnesium intake was shown when com-
pared to the USA RDA (420 mg) for both groups (p ≤ 0.001). 
In females, there was a significant difference between the mean daily Mg intake of 
the hypertensive group and the USA RDA (p ≤ 0.001); however, the normotensives did 
not show a significant difference to the USA recommendations (p = 0.238) (Figure 5). 
 
 
Figure 3. Mean daily dietary Mg intake for both males and females, (HT + NT) decreases 
with age. Error bars showing SEM. 
 
 
Figure 4. Male mean daily magnesium intakes (mean ± SD) for HT and NT groups com-
pared with the USA RDA (+denotes significant difference between HT and USA RDA, 
*denotes significant difference between HT and NT of p ≤ 0.05. 
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Figure 5. Female mean daily magnesium intake (mean ± SD) for HT and NT against 
USA RDA (*denotes significance of p ≤ 0.05. This can be seen between the HT and 
the USA RDA). 
 
The UK general adult population’s mean daily Mg intakes of 270 mg and 221.4 mg 
(90% and 82% of the RNI) for males and females respectively, represented 64% and 
69% of the USA RDA. 
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The primary finding from the current study is that hypertensive females appear to have 
a significantly lower intake of dietary magnesium than normotensive females. Both 
male and female hypertensives appear to have low dietary Mg intake when compared to 
both the RNI and RDA. 
Analysis based on individual sexes elicited different results with observed males de- 
monstrating a significantly lower daily dietary magnesium intake compared to both the 
GP and the RNI. The daily intake of the HT group was 94 mg/day less than the RNI and 
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group. The normotensives demonstrated a trend (as evidenced by a moderate effect size 
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general population and therefore significance was expected. The large standard devia-
tion may have affected the statistical results but in real terms both the NT and GP had a 
similar intake in males. 
Females showed a significant difference between both the NT and the RNI although 
the GP did not show a significant difference compared with the HT group. The GP was 
only 82% of the RNI, a low value which was also seen in the HT group’s daily intake. 
However, female NT’s mean daily intake of magnesium was above the RNI, the only 
group to have met this recommendation. As the NT groups are considered normoten-
sive, it can be suggested that low magnesium intake (82% of the RNI), does not have a 
negative effect on blood pressure; however, the reduction of a further 24 mg/day as 
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found in the HT group may be important in explaining hypertension. It would be of 
interest to see if the GP group developed hypertension over time due to their low mag-
nesium intake and thought must also be given to the previously mentioned fact that 
25% of the general population in the UK is thought to be hypertensive [25]. 
In this study, the difference between Mg intakes of the HT and NT groups was small, 
however, the GP is already below the RNI suggesting that when this further decrease in 
Mg intake is seen the long term consequence on BP could be even greater.  
When mean male intake of 206 mg for the HT group across all ages is compared to 
the RNI the hypertensive patients have a significantly lower intake than recommended. 
Furthermore, the NDNS [26] states that generally males are at approximately 90% of 
the RNI, The NT group of healthy individuals were actually at 96%, supporting these 
findings. Although both the HT and the NT group were below the RNI, NDNS [26] da-
ta used for the GP group showed that only 5% and 7% of the cohort (male and female 
respectively) had hypertension between the ages 19 - 64 y, increasing to 36% and 33% 
for the 65 y+ group. This results in mean hypertension of 21 and 20% for males and 
females in total, slightly below the established norm according to Public Health Eng-
land [25]. This group (the GP) was at 90% of the RNI but below the expected norm for 
prevalence of hypertension. It can be suggested that Mg intake at 90% of the RNI has a 
small effect on blood pressure reinforcing previously published work showing a re-
duced magnesium intake is correlated with increased blood pressure [6] [28] However, 
the HT male group consumed just 69% of the RNI implying that a lower intake may 
have an effect on blood pressure.  
For females the HT group’s mean daily Mg intake was at 196.6 mg/day equating to 
72% of the RNI, while the NT group was above the RNI. Again this may suggest that a 
daily magnesium intake at 72% of the RNI may negatively affect blood pressure in adult 
women.  
The NT group of healthy individuals for the North and East Herts NHS area were at 
96% and 131% of the RNI compared to 90% and 82% for the general population show-
ing that internal validity was higher in males than females. The high intake of dietary 
magnesium in the female NT group was unusual but the cohort was quite small and 
this over consumption only equated to 21 mg/day above the RNI. The Mg intake fig-
ures are also means and therefore it is expected that about half of the subjects will fall 
above this mean value and half will fall below. However, the small female cohort and 
the high standard deviation could both be considered limitations of this work. 
Previous research has shown that magnesium supplementation can have a positive 
effect on blood pressure [6] [28] [29], however the research in the UK is very limited. 
Bain et al. [29], using a UK population base found a greater association between males 
with low magnesium intake and risk of stroke, for which blood pressure is often a pre-
cursor, than in females. However, there is very little research which has examined Mg 
intake in the UK with consequences for blood pressure.  Furthermore, until now, there 
have been no studies observing the habitual dietary intake of those with high blood 
pressure in the UK. Choi and Bae (2015) [15] found that there were a higher percentage 
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of hypertensive males across all dietary magnesium intakes compared to females in the 
Korean population and Itoh (1997) [30] found a blood pressure decrease in 33 healthy 
Japanese who supplemented with magnesium. However Dickinson et al. (2009) [9] 
writing for the Cochrane Review used extensively for recommendations to the medical 
profession in the UK, did not find strong evidence for Mg reducing blood pressure. 
This study hopes to address this matter and move towards showing an association be-
tween those with hypertension and habitual dietary intake low in magnesium. 
In the USA the RDA, set at 320 and 420 mg/d for females and males respectively, is 
higher than the RNI of the UK. As a comparison, the data from this UK study was also 
compared with the USA RDA and the results showed a significantly lower intake than 
recommended by the USA for all population groups. The UK general population’s 
mean intake of 270 mg and 221.4 mg (90% and 82% of the RNI) for males and females 
respectively, represented only 64% and 69% of the USA RDA.  
Previous research has shown that 48% of the general population in the USA was be-
low the RDA in 2005-2006, with rising calcium to magnesium ratios implicated in the 
rise of diabetes and stroke over the past 20 years [3]. Touyz [31], stated that magnesium 
may reduce arterial thickening and abnormal vascular tone as well as endothelial dys-
function linked with cardiovascular disease and high blood pressure. Therefore, a 
magnesium deficiency may play a role in the pathophysiological processes underlying 
blood pressure elevation. 
With the exception of females in the 51 - 65 y age group, all age groups consumed 
Mg below the RNI. The lowest intake could be seen in the >65 y age groups. In this age 
group, blood pressure increases become more prevalent due to decreases in arterial 
compliance and changes in the endothelial cells. Consideration should be given as to 
whether supplementation of this micronutrient might help reduce blood pressure in-
creases normally seen in the older population group. 
Although the USA has set the RDA at a higher level than the UK, the real issue lies 
with dietary intake and not with the recommendations. Initiatives to increase know-
ledge and awareness of this micronutrient may help to reduce blood pressure in the 
UK, subsequently saving the NHS money on costly drug intervention. Although no 
conclusions can be drawn on the mechanistic role of magnesium in prevention of hy- 
pertension, the current study does provide evidence that further investigation is war-
ranted on the role of dietary magnesium intake in this area.  
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